Adocia SA ADOC.PA

€4.96 €0.07 (1.33%) 1D

Last Updated: May 15, 12:00 AM·XPAR

ADOC.PA Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: February 06, 2026

Report Source: 2025 2nd Quarter Report

Adocia SA

Adocia SA. Stock Analysis ADOC.PA

France Health Care Micro Cap Report:
Adocia SA is a clinical-stage biotechnology company, which engages in the development of medicines from already-approved therapeutic proteins and peptides. The firm specializes in the development of formulations of already-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. Its proprietary technological platform BioChaperone is designed to enhance the effectiveness and/or safety of therapeutic proteins while making them easier for patients to use. The Company’s clinical pipeline includes four novel insulin formulations for the treatment of diabetes: two formulations of insulin analog lispro (BioChaperone Lispro U100 and U200), a combination of basal insulin glargine and insulin lispro (BioChaperone Combo), and a combination of prandial insulin with amylin analog pramlintide: M1Pram. Its preclinical pipeline includes three products BioChaperone LisPram, BioChaperone Glargine GLP-1 and BioChaperone Glucagon GLP1.
Read More

Adocia SA (ADOC.PA) Chart

Key Statistics of Adocia SA (ADOC.PA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€4.90€5.25

Today's Open

€5.03

Volume

33.32K

P/E Ratio (TTM)

-

52 Week Range

€3.30€12.40

Market Cap

91.62M

Avg. Volume

44.70K

Dividend Yield

-

Financial Metrics & Statements of Adocia SA (ADOC.PA)

Community-Curated Collections with Adocia SA (ADOC.PA) ( With ADOC.PA )

View All

Community-Curated Collections are thoughtfully selected groups of stocks or assets, curated by investors and experts based on shared themes, values, or investment strategies.

FAQ's for Adocia SA (ADOC.PA)

  • According to Musaffa’s Shariah screening methodology, Adocia SA (ADOC.PA) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.